David Fyfield quoted in Pharmaceutical Journal and MedicalHealthNews on the impact of the pregabalin case for second medical use patents
News & Insights
Charles Russell Speechlys advises Vapotherm on the acquisition of Solus Medical
Vapotherm is a publicly traded developer and manufacturer of advanced respiratory technology.
Charles Russell Speechlys launches startup programme during Unbound Festival in Bahrain
A comprehensive programme launched during the Unbound Festival in Bahrain, for start-ups, SMEs and entrepreneurs.